About LETROHET Tablet
Unlock the power of advanced cancer care with LETROHET Tablet. This celebrated formulation contains Letrozole (2.5 mg), a synthetic and enlightened anti-cancer agent tailored for postmenopausal women with hormone receptor-positive breast cancer. Each spectacular box includes 10 strips, ensuring convenient supply for ongoing therapy. LETROHET stands out for its competitive pricing, making premium cancer treatment accessible. Explore the benefits of this trusted medication-just store below 30C, away from sunlight and moisture, for maximum efficacy. Experience reliability with LETROHET, a product proudly distributed, exported, and supplied by renowned manufacturers and traders across India.
Area of Application and Specific Usage
LETROHET Tablet is specifically recommended for postmenopausal women diagnosed with hormone receptor-positive breast cancer. Its area of application lies in oncology, where it inhibits estrogen synthesis to manage cancer progression. Intended for oral use, this tablet is best taken once daily, on a cool and dry surface or as advised by your healthcare professional. LETROHET ensures precision treatment, targeting specific cancer pathways for optimal outcomes in both domestic and export medical markets.
FOB Port, Packaging, and Delivery Information
Shipments of LETROHET Tablet are efficiently managed via major FOB ports across India, ensuring timely delivery to both domestic and export markets. Each package includes 10 strips per box, designed for secure transportation and uncompromised product integrity. Detailed packaging safeguards the tablets from physical damage and environmental exposure. Our streamlined logistics process guarantees prompt delivery, so customers can rely on consistent supply, whether distributed locally or exported internationally.
FAQ's of LETROHET Tablet:
Q: How should LETROHET Tablet be administered for optimal effectiveness?
A: LETROHET Tablet should be taken orally, once daily, with or without food, exactly as prescribed by your healthcare provider. Do not vary the dosage without medical guidance.
Q: What is the primary benefit of using LETROHET Tablet?
A: LETROHET Tablet is formulated to inhibit estrogen production, making it highly effective for treating hormone receptor-positive breast cancer in postmenopausal women, thus supporting improved cancer management.
Q: Where should LETROHET Tablets be stored to maintain quality?
A: Store LETROHET Tablets in a cool, dry place below 30C, and keep them away from direct sunlight and moisture to preserve their potency and effectiveness.
Q: What is included in the packaging of LETROHET Tablet for safe shipment?
A: Each box of LETROHET contains 10 strips, with packaging designed to shield the medication from damage and environmental factors during both domestic and export shipments.
Q: Who is the recommended user for LETROHET Tablet?
A: LETROHET Tablet is specifically recommended for postmenopausal women diagnosed with hormone receptor-positive breast cancer, following a healthcare professional's advice.